-
Something wrong with this record ?
Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index
K. Brat, M. Svoboda, K. Hejduk, M. Plutinsky, J. Zatloukal, E. Volakova, P. Popelkova, B. Novotna, D. Engova, F. M. E. Franssen, L. E. G. W. Vanfleteren, M. A. Spruit, V. Koblizek
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
32955038
DOI
10.5507/bp.2020.035
Knihovny.cz E-resources
- MeSH
- Pulmonary Disease, Chronic Obstructive * mortality MeSH
- Dyspnea MeSH
- Body Mass Index MeSH
- Humans MeSH
- Prognosis MeSH
- Respiratory Function Tests MeSH
- Severity of Illness Index MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: The BODE (BMI, Obstruction - FEV1, Dyspnoea - mMRC, Exercise - 6-MWT) and the ADO (Age, Dyspnoea - mMRC, Obstruction - FEV1) indices are widely used prognosis assessment tools for long-term mortality prediction in COPD patients but subject to limitations for use in daily clinical practice. The aim of this research was to construct a prognostic instrument that prevents these limitations and which would serve as a complementary prognostic tool for clinical use in these patients. METHODS AND PARTICIPANTS: The data of 699 COPD subjects were extracted from the Czech Multicentre Research Database (CMRD) of COPD patients (the derivation cohort) and analysed to identify factors associated with the long-term risk of mortality. These were entered into the ROC analysis and reclassification analysis. Those with the strongest discriminative power were used to construct the new index (CADOT). The new index was validated on 187 patients of the CIROCO+ cohort (Netherlands; the validation cohort). RESULTS: The CADOT was constructed by adding two newly identified prognosis-determining factors, chronic heart failure (CHF) and TLCO, to the ADO index. In a head-to-head comparison, the CADOT index showed highest c-statistic values compared to the BODE and ADO indices (0.701 vs 0.677 vs 0.644, respectively). The prognostic power was more definitive when applied to the Dutch validation (CIROCO+) cohort (0.842 vs 0.799 vs 0.825, respectively). CONCLUSIONS: The CADOT index has comparable prognostic power to the BODE and ADO indices. The CADOT is complementary/an alternative to the BODE (if 6-MWT is not feasible) and ADO (with less dependence on the age factor) indices. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01923051).
Boehringer Ingelheim s r o Prague Czech Republic
COPD Center Sahlgrenska University Hospital Institute of Medicine University of Gothenburg Sweden
Department of Respiratory Diseases University Hospital Brno Brno Czech Republic
Department of Respiratory Medicine University Hospital Olomouc Czech Republic
Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Biostatistics and Analyses Ltd Brno Czech Republic
Pulmonary Department Bulovka Hospital Prague Czech Republic
Pulmonary Department University Hospital Ostrava Czech Republic
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22007869
- 003
- CZ-PrNML
- 005
- 20220401110851.0
- 007
- ta
- 008
- 220309s2021 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2020.035 $2 doi
- 035 __
- $a (PubMed)32955038
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Brat, Kristián $7 xx0224637 $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index / $c K. Brat, M. Svoboda, K. Hejduk, M. Plutinsky, J. Zatloukal, E. Volakova, P. Popelkova, B. Novotna, D. Engova, F. M. E. Franssen, L. E. G. W. Vanfleteren, M. A. Spruit, V. Koblizek
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: The BODE (BMI, Obstruction - FEV1, Dyspnoea - mMRC, Exercise - 6-MWT) and the ADO (Age, Dyspnoea - mMRC, Obstruction - FEV1) indices are widely used prognosis assessment tools for long-term mortality prediction in COPD patients but subject to limitations for use in daily clinical practice. The aim of this research was to construct a prognostic instrument that prevents these limitations and which would serve as a complementary prognostic tool for clinical use in these patients. METHODS AND PARTICIPANTS: The data of 699 COPD subjects were extracted from the Czech Multicentre Research Database (CMRD) of COPD patients (the derivation cohort) and analysed to identify factors associated with the long-term risk of mortality. These were entered into the ROC analysis and reclassification analysis. Those with the strongest discriminative power were used to construct the new index (CADOT). The new index was validated on 187 patients of the CIROCO+ cohort (Netherlands; the validation cohort). RESULTS: The CADOT was constructed by adding two newly identified prognosis-determining factors, chronic heart failure (CHF) and TLCO, to the ADO index. In a head-to-head comparison, the CADOT index showed highest c-statistic values compared to the BODE and ADO indices (0.701 vs 0.677 vs 0.644, respectively). The prognostic power was more definitive when applied to the Dutch validation (CIROCO+) cohort (0.842 vs 0.799 vs 0.825, respectively). CONCLUSIONS: The CADOT index has comparable prognostic power to the BODE and ADO indices. The CADOT is complementary/an alternative to the BODE (if 6-MWT is not feasible) and ADO (with less dependence on the age factor) indices. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01923051).
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a dyspnoe $7 D004417
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a chronická obstrukční plicní nemoc $x mortalita $7 D029424
- 650 _2
- $a respirační funkční testy $7 D012129
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Svoboda, Michal $7 xx0230935 $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Hejduk, Karel $7 xx0227632 $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Plutinský, Marek $7 xx0255631 $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Zatloukal, Jaromír $7 xx0113000 $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic
- 700 1_
- $a Voláková, Eva, $d 1971- $7 xx0223802 $u Department of Respiratory Medicine, University Hospital Olomouc, Czech Republic
- 700 1_
- $a Popelková, Patrice $7 xx0104407 $u Pulmonary Department, University Hospital Ostrava, Czech Republic
- 700 1_
- $a Novotná, Barbora $7 xx0231471 $u Pulmonary Department, Bulovka Hospital, Prague, Czech Republic
- 700 1_
- $a Engová, Dita, $d 1970- $7 xx0271515 $u Boehringer Ingelheim s.r.o., Prague, Czech Republic
- 700 1_
- $a Franssen, Frits M. E. $u Department of Research and Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands $u Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands
- 700 1_
- $a Vanfleteren, Lowie E. G. W. $u COPD Center, Sahlgrenska University Hospital, Institute of Medicine, University of Gothenburg, Sweden
- 700 1_
- $a Spruit, Martijn A. $u Department of Research and Education, CIRO, Center of Expertise for Chronic Organ Failure, Horn, The Netherlands $u REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium $u Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands
- 700 1_
- $a Koblížek, Vladimír, $d 1970- $7 xx0076215 $u Pulmonary Department, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 165, č. 2 (2021), s. 139-145
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32955038 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20220309 $b ABA008
- 991 __
- $a 20220401110843 $b ABA008
- 999 __
- $a ok $b bmc $g 1775506 $s 1159062
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 165 $c 2 $d 139-145 $e 20200910 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20220309